ClinicalTrials.gg
Not yet recruitingNCT07823634Updated Sep 16, 2026

Development and Preliminary Application Evaluation of a Clinical Decision Support Training Platform for Dementia Care

An interventional study of care decision support training platform program in Education, Professional, Decision Making and Dementia, sponsored by Chang Gung Memorial Hospital. Not yet recruiting. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Not applicable
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Dementia by Chang Gung Memorial Hospital — 9 open to participants now, 10 under way, none of them phase 3. Dementia · Chang Gung Memorial Hospital.

Planned enrollment
7th of 21
130 · median 97
Started
2026
with 4 others
No phase
12 of 23
5 open now
Registered
23rd of 23
by date

Among the 23 studies in Dementia by Chang Gung Memorial Hospital, this one is the 7th largest by planned enrollment of the 21 interventional ones that give a count, is one of 5 that started in 2026, is one of 12 with no phase, and was the 23rd registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

9 of the 23 studies in Dementia by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 20 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Dementia by Chang Gung Memorial Hospital, or all of them as a file.
02

Study summary

This study consists of two phases: an observational phase and a single-arm interventional phase. In Phase 1, qualitative interviews will be conducted to explore the decision-making challenges faced by second-year students in a two-year undergraduate program who are approaching graduation when providing care for people with dementia. In Phase 2, a single-arm intervention will be implemented using an interactive web-based digital clinical decision support training platform. The following research questions will be examined:

  1. Does the interactive web-based digital clinical decision support training platform significantly improve students' decision-making competency in providing assistance with activities of daily living for people with dementia?
  2. Does the interactive web-based digital clinical decision support training platform significantly improve students' judgment competency in managing behavioral problems associated with dementia?
  3. Does the interactive web-based digital clinical decision support training platform significantly improve students' competency in supporting family caregivers experiencing caregiving burden and in connecting them with appropriate resources?
03

Conditions studied

  • Education, Professional
  • Decision Making
  • Dementia

Browse trials for

Keywords

  • Novice
  • healthcare professional
  • training
  • decision support training
04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria in Phase 1:

  1. Aged 20 years or older.
  2. Willing to provide written .
  3. Currently a second-year student in the Department of Gerontology and Health Care Management.
  4. Has prior practicum experience in geriatric care or practical experience in dementia care.
  5. Voluntarily agrees to participate in the study.

Inclusion Criteria in Phase 2:

  1. Aged 20 years or older.
  2. Willing to provide written informed consent.
  3. Currently a second-year student in the Department of Gerontology and Health Care Management.
  4. Has prior practicum experience in geriatric care or practical experience in dementia care.
  5. Voluntarily agrees to participate in the study.
  6. Able to operate the information platform. Exclusion Criteria in Phase 1 and 2: Students who have taken a leave of absence from school or who decline to provide informed consent to participate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    care decision support training group

    The care decision support training group will receive an educational intervention using an interactive web-based digital care decision support training platform.

    Other: care decision support training platform program

Interventions

  • Othercare decision support training platform program

    The participants will receive an educational intervention using an interactive web-based digital care decision support training platform. The training is centered on scenario-based modules and incorporates guidance on decision branches, situational judgment, and care plan development.

06

What researchers measure

Primary outcomes

  1. Dementia Care Professional Competency Assessment Scale

    1. The Dementia Care Professional Competency Assessment Scale was developed in our previous research supported by the Taiwan Ministry of Science and Technology (Grant No. 106-2511-S-255-002-MY3) to assess dementia care competency among students. 2. The original scale contains nine subscales with 74 items. In this study, three subscales comprising 33 items are used. Each item is rated on a 5-point Likert scale from 1 to 5, with higher scores indicating greater dementia care competency.

    Time frame: Baseline and after completion of all training modules (up to 18 weeks)

Secondary outcomes

  1. Problem solving, Teamwork Competency Assessment Scale

    1. The Dementia Care Professional Competency Assessment Scale was developed in our previous research supported by the Taiwan Ministry of Science and Technology (Grant No. 106-2511-S-255-002-MY3) to assess dementia care competency among students. 2. The scale contains 22 items, including 10 items assessing problem-solving competency and 12 items assessing teamwork competency. Higher scores indicate greater problem-solving and teamwork competency.

    Time frame: Baseline and after completion of all training modules (up to 18 weeks)

  2. Participants' Experiences and Feedback on the Training Program

    Students will complete a feedback form to provide their perceptions and experiences regarding the interactive web-based care decision support training program. The form includes open-ended questions regarding their learning experiences, perceived usefulness of the training, difficulties encountered, and suggestions for improvement. Qualitative responses will be analyzed to explore participants' experiences and perspectives regarding the training program.

    Time frame: After completion of all training modules (up to 18 weeks)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — There is currently no plan to share individual participant data from this study with other researchers. Participants may separately consent to the future use of their de-identified data for related research. Any such future use will be subject to applicable ethical review and the scope of the participant's consent.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jun 2027, 8 months later.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 8 months is below that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2026
First posted
Sep 16, 2026
StartEst.
Oct 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jul 2027
Last update
Sep 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07823634
Collaborators
National Science and Technology Council, Taiwan, Chang Gung University of Science and Technology
Responsible party
Huei-Ling Huang (Professor, PhD, RN, Department of Gerontology and Health Care Management, College of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan, R.O.C, Chang Gung Memorial Hospital) — Principal investigator
First posted
Sep 16, 2026
Start date
Oct 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Sep 16, 2026

Study contacts

Huei-Ling Huang, PhD
Contact
hlhuang@mail.cgust.edu.tw
+886-3-2118999 ext. 5803

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion